You are here: Industry Insights > Takeda

News List

Moderna partners with Takeda for Covid-19 vaccines supply to Japan pharmaceutical-technology
November 02, 2020
Moderna has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical agreed to purchase and distribute 50 million doses of its Covid-19 vaccine candidate, mRNA-1273.
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan worldpharmanews
October 30, 2020
Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna's COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. This effort is part of a three-way ...
Takeda enters $1.04bn deal with Arrowhead Pharmaceuticals pharmaceutical-technology
October 16, 2020
Takeda has entered a collaboration and licensing agreement with Arrowhead Pharmaceuticals to develop an investigational drug, ARO-AAT, for the treatment of alpha-1 antitrypsin-associated liver disease (AATLD).
Takeda sells select non-core assets in Europe to Cheplapharm for about $562 mn expresspharma
September 17, 2020
Portfolio includes prescription products in Takeda’s cardiovascular/metabolic and anti-inflammatory therapeutic areas along with calcium.
Takeda Opens R&D Cell Therapy Mfg. Facility in Boston contractpharma
September 16, 2020
Will support expansion of next-generation clinical programs, including five collaborative oncology cell therapy programs entering trials.
Engitix signs drug discovery and licensing deal with Takeda pharmaceutical-technology
August 27, 2020
UK-based biotechnology firm Engitix has signed a licensing and collaboration agreement with Takeda Pharmaceutical for the discovery and development of new drugs to treat fibrotic liver diseases.
Takeda to offload Japan consumer health unit to Blackstone for $2.3 billion fiercepharma
August 26, 2020
After months of rumors, Takeda has finally unveiled a deal to sell its Japanese consumer health business to Blackstone Group.
Takeda signs deal with UK biotech Engitix pharmatimes
August 26, 2020
Takeda has signed a licensing agreement with UK biotech Engitix to develop new therapies for advanced fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH).
Takeda to sell consumer healthcare unit in Japan for $2.28bn pharmaceutical-technology
August 25, 2020
Takeda Pharmaceutical has signed an agreement to sell its Consumer Healthcare unit to investment firm The Blackstone Group for JPY242bn ($2.28bn).
Takeda to license Novavax’ Covid-19 vaccine candidate NVX‑CoV2373 pharmaceutical-business-review
August 12, 2020
Novavax has agreed to grant the Japanese licensing rights to NVX‑CoV2373, a vaccine candidate modified from the genetic sequence of the Covid-19 causing SARS‑CoV‑2 virus, to Takeda Pharmaceutical.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page